Phase 3, CXCR4 Chemokine Receptor Antagonist, >=1 prior line of therapy, Granulocyte Colony-Stimulating Factor+Placebo (G-CSF+Placebo), Relapsed Refractory Multiple Myeloma (RRMM), Granulocyte Colony-Stimulating Factor+Plerixafor (G-CSF+Plerixafor)
### Instruction:
Identify the study with the following condition. 
### Input:
Phase 3, CXCR4 Chemokine Receptor Antagonist, >=1 prior line of therapy, Granulocyte Colony-Stimulating Factor+Placebo (G-CSF+Placebo), Relapsed Refractory Multiple Myeloma (RRMM), Granulocyte Colony-Stimulating Factor+Plerixafor (G-CSF+Plerixafor) 
### Output:
Popular Name is AMD3100-3102, Study ID is NCT00103662